Success Metrics

Clinical Success Rate
100.0%

Based on 19 completed trials

Completion Rate
100%(19/19)
Active Trials
4(14%)
Results Posted
47%(9 trials)

Phase Distribution

Ph phase_2
7
25%
Ph phase_4
5
18%
Ph early_phase_1
2
7%
Ph not_applicable
7
25%
Ph phase_3
4
14%
Ph phase_1
3
11%

Phase Distribution

5

Early Stage

7

Mid Stage

9

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
2(7.1%)
Phase 1Safety & dosage
3(10.7%)
Phase 2Efficacy & side effects
7(25.0%)
Phase 3Large-scale testing
4(14.3%)
Phase 4Post-market surveillance
5(17.9%)
N/ANon-phased studies
7(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.0%

19 of 20 finished

Non-Completion Rate

5.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

28

all time

Status Distribution
Active(5)
Completed(19)
Terminated(1)
Other(3)

Detailed Status

Completed19
Recruiting3
unknown3
Withdrawn1
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (7.1%)
Phase 13 (10.7%)
Phase 27 (25.0%)
Phase 34 (14.3%)
Phase 45 (17.9%)
N/A7 (25.0%)

Trials by Status

withdrawn14%
active_not_recruiting14%
enrolling_by_invitation14%
recruiting311%
completed1968%
unknown311%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT05211401Phase 2

Rituximab in Patients With ST-elevation Myocardial Infarction

Recruiting
NCT03153527Phase 4

Taper Or Abrupt Steroid Stop: TOASSTtrial

Recruiting
NCT07517068Early Phase 1

The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude

Active Not Recruiting
NCT07504952Not Applicable

Investigating the Impact of Probiotics on Wellbeing in a Community

Completed
NCT06925152Phase 4

COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block

Recruiting
NCT07253155Not Applicable

Probiotics Use and Preventing Gastrointestinal Symptoms in People Living With Overweight and Obesity.

Enrolling By Invitation
NCT07150533Not Applicable

Green Tea Extract and Ginger

Completed
NCT03253328Early Phase 1

N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes

Completed
NCT00156104Phase 3

Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)

Completed
NCT03243058Phase 1

Low-dose IL-2 in Established T1D - The "PROREG" Study

Withdrawn
NCT03181893Phase 2

A Study In Adults With Moderate To Severe Dermatomyositis

Completed
NCT00908050Phase 4

Study of the Safety and Efficacy of Botox in Bruxism

Completed
NCT03926611Phase 2

This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

Completed
NCT00378508Phase 2

Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes

Completed
NCT01959113Phase 1

Validation of the Short-term Antimicrobial Action of Transplanted Bacteria

Completed
NCT03386448Phase 4

The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression

Completed
NCT03215979Not Applicable

Use of Platelet-enriched Plasma During Auricular Reconstruction

Unknown
NCT02212990Not Applicable

The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine

Completed
NCT01133730Not Applicable

Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft

Completed
NCT03369795Phase 2

Add-on Methotrexate for the Treatment of Schizophrenia

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
28